临床医生与患者报告癌症临床试验中不良事件评估的基线和基线后症状。
Clinician vs Patient Reporting of Baseline and Postbaseline Symptoms for Adverse Event Assessment in Cancer Clinical Trials.
机构信息
Memorial Sloan Kettering Cancer Center, New York, New York.
Alliance Statistics and Data Center, Mayo Clinic, Scottsdale, Arizona.
出版信息
JAMA Oncol. 2020 Mar 1;6(3):437-439. doi: 10.1001/jamaoncol.2019.5566.
Abstract
This retrospective analysis of clinical trials compares clinician reporting of adverse events and patient reporting of analogous symptoms.
摘要
本回顾性临床试验分析比较了临床医生报告的不良事件和患者报告的类似症状。
相似文献
1
Clinician vs Patient Reporting of Baseline and Postbaseline Symptoms for Adverse Event Assessment in Cancer Clinical Trials.临床医生与患者报告癌症临床试验中不良事件评估的基线和基线后症状。
JAMA Oncol. 2020 Mar 1;6(3):437-439. doi: 10.1001/jamaoncol.2019.5566.
2
Methods for Implementing and Reporting Patient-reported Outcome (PRO) Measures of Symptomatic Adverse Events in Cancer Clinical Trials.癌症临床试验中有症状不良事件的患者报告结局（PRO）测量的实施与报告方法
Clin Ther. 2016 Apr;38(4):821-30. doi: 10.1016/j.clinthera.2016.03.011. Epub 2016 Apr 2.
3
Eliciting the child's voice in adverse event reporting in oncology trials: Cognitive interview findings from the Pediatric Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events initiative.在肿瘤学试验的不良事件报告中引出儿童的声音：不良事件通用术语标准儿科患者报告结局版本的认知访谈结果
Pediatr Blood Cancer. 2017 Mar;64(3). doi: 10.1002/pbc.26261. Epub 2016 Sep 21.
4
Exploration of baseline patient-reported side effect bother from cancer therapy.探讨癌症治疗中基线患者报告的副作用困扰。
Clin Trials. 2020 Jun;17(3):332-337. doi: 10.1177/1740774520910389. Epub 2020 Mar 10.
5
Mapping child and adolescent self-reported symptom data to clinician-reported adverse event grading to improve pediatric oncology care and research.将儿童和青少年自我报告的症状数据与临床医生报告的不良事件分级进行映射，以改善儿科肿瘤学的护理和研究。
Cancer. 2020 Jan 1;126(1):140-147. doi: 10.1002/cncr.32525. Epub 2019 Sep 25.
6
Feasibility Assessment of Using the Complete Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) Item Library.使用完整的患者报告结局版常见不良事件术语标准（PRO-CTCAE）项目库的可行性评估。
Oncologist. 2019 Apr;24(4):e146-e148. doi: 10.1634/theoncologist.2018-0332. Epub 2019 Feb 6.
7
Adverse Event Reporting in Cancer Clinical Trials: Incorporating Patient-Reported Methods. A Systematic Scoping Review.癌症临床试验中的不良事件报告：纳入患者报告方法。系统范围综述。
Patient. 2024 Jul;17(4):335-347. doi: 10.1007/s40271-024-00689-4. Epub 2024 Apr 8.
8
Patient free text reporting of symptomatic adverse events in cancer clinical research using the National Cancer Institute's Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE).使用美国国家癌症研究所的患者报告结局版常见不良事件术语标准（PRO-CTCAE），对癌症临床研究中的症状性不良事件进行患者自由文本报告。
J Am Med Inform Assoc. 2019 Apr 1;26(4):276-285. doi: 10.1093/jamia/ocy169.
9
Acceptability of Routine Evaluations Using Patient-Reported Outcomes of Common Terminology Criteria for Adverse Events and Other Patient-Reported Symptom Outcome Tools in Cancer Outpatients: Princess Margaret Cancer Centre Experience.在癌症门诊患者中使用通用不良事件术语标准和其他患者报告症状结局工具进行常规评估的可接受性：玛格丽特公主癌症中心的经验。
Oncologist. 2019 Nov;24(11):e1219-e1227. doi: 10.1634/theoncologist.2018-0830. Epub 2019 Aug 13.
10
PROceeding With the Patient-Reported Outcomes (PROs) Version of the Common Terminology Criteria for Adverse Events.采用患者报告的不良事件通用术语标准（PROs）版本。
JAMA Oncol. 2015 Nov;1(8):1059-60. doi: 10.1001/jamaoncol.2015.2689.
引用本文的文献
1
Patient-Reported Side Effect Bother: Understanding the Value of the Baseline Report.患者报告的副作用困扰：理解基线报告的价值。
Patient. 2025 Aug 28. doi: 10.1007/s40271-025-00766-2.
2
Optimizing abemaciclib-induced diarrhea management in patients with breast cancer: a pragmatic 2-group study using a postbiotic microbiota stabilizer.优化乳腺癌患者阿贝西利引起的腹泻管理：使用后生元菌群稳定剂的实用 2 组研究。
Oncologist. 2024 Sep 6;29(9):e1113-e1119. doi: 10.1093/oncolo/oyae101.
3
Adverse Event Reporting in Cancer Clinical Trials: Incorporating Patient-Reported Methods. A Systematic Scoping Review.癌症临床试验中的不良事件报告：纳入患者报告方法。系统范围综述。
Patient. 2024 Jul;17(4):335-347. doi: 10.1007/s40271-024-00689-4. Epub 2024 Apr 8.
4
Experience of patients considering or using checkpoint inhibitors in cancer treatment: a systematic review of qualitative research.癌症治疗中考虑或使用检查点抑制剂的患者体验：定性研究的系统评价。
J Immunother Cancer. 2024 Jan 11;12(1):e007555. doi: 10.1136/jitc-2023-007555.
5
Analysis of patient-reported outcomes in the approval of novel oncology drugs in the United States, 2017-2022.2017 - 2022年美国新型肿瘤药物获批中患者报告结局的分析
EClinicalMedicine. 2023 Apr 6;59:101953. doi: 10.1016/j.eclinm.2023.101953. eCollection 2023 May.
6
Construct validity and responsiveness of a health-related symptom index for persons either treated or monitored for anal high-grade squamous intraepithelial lesions (HSIL): AMC-A01/-A03.用于治疗或监测肛门高级别鳞状上皮内病变（HSIL）患者的健康相关症状指数的构建效度和反应度：AMC-A01/-A03。
Qual Life Res. 2023 Aug;32(8):2293-2304. doi: 10.1007/s11136-023-03391-4. Epub 2023 Apr 5.
7
A Narrative Review on the Collection and Use of Electronic Patient-Reported Outcomes in Cancer Survivorship Care with Emphasis on Symptom Monitoring.电子患者报告结局在癌症生存者照护中的采集和应用述评，重点关注症状监测。
Curr Oncol. 2022 Jun 17;29(6):4370-4385. doi: 10.3390/curroncol29060349.
8
Incidence of fatigue associated with immune checkpoint inhibitors in patients with cancer: a meta-analysis.癌症患者使用免疫检查点抑制剂相关疲劳的发生率：一项荟萃分析。
ESMO Open. 2022 Jun;7(3):100474. doi: 10.1016/j.esmoop.2022.100474. Epub 2022 May 13.
9
Evaluating Treatment Tolerability Using the Toxicity Index With Patient-Reported Outcomes Data.使用基于患者报告结局数据的毒性指数评估治疗耐受性。
J Pain Symptom Manage. 2022 Feb;63(2):311-320. doi: 10.1016/j.jpainsymman.2021.07.031. Epub 2021 Aug 8.
10
Evolution of Hematology Clinical Trial Adverse Event Reporting to Improve Care Delivery.血液学临床试验不良事件报告的演变，以改善护理服务。
Curr Hematol Malig Rep. 2021 Apr;16(2):126-131. doi: 10.1007/s11899-021-00627-3. Epub 2021 Mar 30.
本文引用的文献
1
Patient-reported outcomes: an essential component of oncology drug development and regulatory review.患者报告的结局：肿瘤药物研发与监管审评的重要组成部分。
Lancet Oncol. 2018 May;19(5):595-597. doi: 10.1016/S1470-2045(18)30141-4.
2
Patient-Reported Outcomes - Harnessing Patients' Voices to Improve Clinical Care.患者报告结局——利用患者声音改善临床护理。
N Engl J Med. 2017 Jan 12;376(2):105-108. doi: 10.1056/NEJMp1611252.
3
Methods for Implementing and Reporting Patient-reported Outcome (PRO) Measures of Symptomatic Adverse Events in Cancer Clinical Trials.癌症临床试验中有症状不良事件的患者报告结局（PRO）测量的实施与报告方法
Clin Ther. 2016 Apr;38(4):821-30. doi: 10.1016/j.clinthera.2016.03.011. Epub 2016 Apr 2.
4
Missing Patients' Symptoms in Cancer Care Delivery--The Importance of Patient-Reported Outcomes.癌症护理中患者症状的遗漏——患者报告结局的重要性。
JAMA Oncol. 2016 Apr;2(4):433-4. doi: 10.1001/jamaoncol.2015.4719.
5
Note on the sampling error of the difference between correlated proportions or percentages.关于相关比例或百分比差异的抽样误差说明。
Psychometrika. 1947 Jun;12(2):153-7. doi: 10.1007/BF02295996.
Zotero 插件